Losartan: all 246 studies that test it
Page 2 of 3. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.
- Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19Active, not recruitingNCT05619653Phase 3
- Losartan in Prevention of Radiation-Induced Heart FailureCompletedNCT05607017Early Phase 1
- Losartan and Uric Acid Metabolism in Children With Proteinuric NephropathiesCompletedNCT05402397Phase 4
- Hypertension in Young Adults TrialTerminatedNCT05370599Phase 2
- PHL Treatment in Pancreatic CancerActive, not recruitingNCT05365893Early Phase 1
- Losartan Use to Mitigate Arthrofibrosis Following Total Join ArthroplastyWithdrawnNCT05157464Phase 4
- Effects of Angiotensin Converting Enzyme Inhibitors on Patency of Arterio-Venous Fistulas: A Randomized Controlled TrialStatus unknownNCT05132712Early Phase 1
- Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of ChemotherapyStatus unknownNCT05097248Phase 2
- Non-interaction Study of Chlorthalidone and Losartan in Fixed Combination, in Healthy Subjects, Under Fasting ConditionsCompletedNCT05090449Phase 1
- FOLFIRINOX + Elraglusib + Losartan In Pancreatic CancerActive, not recruitingNCT05077800Phase 2
- Losartan for Diffuse Myocardial Fibrosis in Sickle Cell DiseaseCompletedNCT05012631Phase 2
- Effect of Losartan or Eprosartan on Fructose HyperuricemiaCompletedNCT04954560Not applicable
- Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for OsteoarthritisActive, not recruitingNCT04815902Phase 1/2
- Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDSTerminatedNCT04643691Phase 2
- Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?TerminatedNCT04606563Phase 3
- Losartan Effects on Emotion-memory InteractionStatus unknownNCT04606225Not applicable
- The Effects of Losartan on Emotion ProcessingStatus unknownNCT04606212Not applicable
- The Effects of Losartan on Reward Reinforcement LearningStatus unknownNCT04604938Not applicable
- The Effects of Losartan on Social RewardStatus unknownNCT04604756Not applicable
- Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 InfectionTerminatedNCT04447235Phase 2
- The Fleming [FMTVDM] Directed CoVid-19 Treatment ProtocolCompletedNCT04349410Phase 2/3
- Coronavirus Response - Active Support for Hospitalised Covid-19 PatientsWithdrawnNCT04343001Phase 3
- COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19TerminatedNCT04328012Phase 2/3
- The Effect of Losartan on the Recoverability of Renal Function in Anuric and Oliguric Patients With Unilateral Obstructed KidneyCompletedNCT04278495Not applicable
- Pharmacokinetics of HCP1401 and Co-administration of HCP0605, HGP1405 in Healthy Male VolunteersCompletedNCT04252872Phase 1
- Renohemodynamic Effects of Combined empagliflOzin and LosARtanCompletedNCT04238702Phase 4
- Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics PatientsCompletedNCT04222686Phase 4
- Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic CancerCompletedNCT04106856Phase 1
- Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without DiabetesWithdrawnNCT03978884Phase 4
- The Pharmacokinetic Interaction Between Amlodipine and LosartanCompletedNCT03912285Phase 1
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- Losartan and Emotional MemoryCompletedNCT03763409Not applicable
- Nighttime Losartan in Continous Ambulatory Peritoneal Dialysis (NVCAPD)Status unknownNCT03692013Phase 4
- Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VIStatus unknownNCT03632213Phase 2
- Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial HypertensionStatus unknownNCT03626259Phase 4
- Fixed-Free HTN TrialStatus unknownNCT03578042Phase 4
- Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic CancerActive, not recruitingNCT03563248Phase 2
- Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus NephritisStatus unknownNCT03526042Not applicable
- A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting ConditionsCompletedNCT03459911Phase 1
- Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240CompletedNCT03435939Early Phase 1
- The Effect of Losartan on Emotional Processing in Healthy VolunteersCompletedNCT03434054Not applicable
- Losartan and Emotion ProcessingStatus unknownNCT03396523Not applicable
- Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1Status unknownNCT03357653Phase 3
- AT1R Blockade and Periodic Breathing During Sleep in HypoxiaCompletedNCT03335904Phase 4
- A Study on Molecular Genetics of Drug Responsiveness in Essential HypertensionCompletedNCT03276598Phase 4
- Matão Controlling Hypertension (MatCH Study): Rationale and DesignStatus unknownNCT03147092Early Phase 1
- Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein StenosisSuspendedNCT02769130Phase 1/2
- N-of-1 Trials for Blood Pressure Medications in AdultsCompletedNCT02744456Early Phase 1
- Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular EdemaCompletedNCT02663141Phase 2
- Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive PatientsCompletedNCT02294539Phase 4
- Study of High Dosage of Losartan in Comparison to Low Dose of Losartan in Heart Failure PatientsWithdrawnNCT02238457Phase 4
- Efficacy and Safety of Losartan in Children With Ig A NephropathyCompletedNCT02232776Phase 3
- Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular ProteinuriaCompletedNCT02232763Phase 3
- Efficacy and Safety of Abelmoschus Manihot for IgA NephropathyStatus unknownNCT02231125Phase 4
- the Pharmacokinetic Profiles of Losartan With DW1029MCompletedNCT02212769Phase 1
- A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT02200653Phase 4
- A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT02200640Phase 4
- Residual Renal Function Preservation in Peritoneal Dialysis PatientsStatus unknownNCT02190318Not applicable
- Efficacy and Safety of Shenyankangfu Tablets for Primary GlomerulonephritisStatus unknownNCT02063100Phase 4
- Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone SystemStatus unknownNCT02010905Phase 2
- Losartan for Sickle Cell Kidney DiseaseCompletedNCT01989078Early Phase 1
- Comparision of Blood Pressure Variability Between Amlodipine and LosartanCompletedNCT01964079Phase 4
- Drug-Drug Interaction Study With PF-05089771CompletedNCT01934569Phase 1
- Pharmacokinetic Interactions of Losartan and HydrochlorothiazideCompletedNCT01858623Not applicable
- Losartan in Decompensated Heart FailureCompletedNCT01857999Phase 4
- Angiotensin II Receptor Blockers, Steroids and Radiotherapy in GlioblastomaCompletedNCT01805453Phase 3
- Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting ConditionsCompletedNCT01797926Phase 1
- Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + HydrochlorothiazideCompletedNCT01692717Phase 1
- Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension TreatmentSuspendedNCT01620788Phase 3
- Development of Minidose Inje Cocktail Method for Simultaneous Evaluating Five Cytochrome P450 Isoforms in HumanCompletedNCT01570569Phase 1
- Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic CardiomyopathyCompletedNCT01447654Phase 2
- Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene MutationsStatus unknownNCT01320397Phase 2
- The Effect of Aliskiren and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis PatientsStatus unknownNCT01305850Phase 4
- Contribution of Angiotensin II to Supine Hypertension in Autonomic FailureTerminatedNCT01292694Phase 1
- PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung CancerCompletedNCT01281787Phase 3
- Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic SyndromeStatus unknownNCT01271374Phase 4
- Telmisartan Versus Losartan in Kidney TransplantationCompletedNCT01224860Phase 2
- Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fed ConditionsCompletedNCT01218724Phase 1
- Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions.CompletedNCT01218711Phase 1
- Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fed ConditionCompletedNCT01218698Phase 1
- Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fasting ConditionCompletedNCT01218022Phase 1
- Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed ConditionsCompletedNCT01216878Not applicable
- Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted ConditionsCompletedNCT01216852Not applicable
- Local Vasoconstriction in Postural Tachycardia SyndromeCompletedNCT01210430Early Phase 1
- Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular SchwannomaActive, not recruitingNCT01199978Phase 2
- Recurrent Stroke Prevention Clinical Outcome StudyStatus unknownNCT01198496Phase 4
- A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and LosartanCompletedNCT01197014Phase 1
- A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and LosartanCompletedNCT01197001Phase 1
- Pharmacokinetic Study to Investigate Low-dose Combinations of a Cocktail of Seven Drugs for Simultaneous Phenotyping of CytochromesCompletedNCT01187862Phase 1
- Intensive Vasodilator Therapy in Patients With Essential HypertensionCompletedNCT01180413Phase 4
- Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan SyndromeStatus unknownNCT01145612Phase 3
- Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 HypertensionCompletedNCT01127217Phase 3
- Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted ConditionsCompletedNCT01102478Not applicable
- Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy VolunteersCompletedNCT01087749Phase 1
- Anti-Fibrotic Effects of Losartan In Nash Evaluation StudyCompletedNCT01051219Phase 3
- The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis PatientsStatus unknownNCT01041963Phase 4
- Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 DiabetesCompletedNCT01011062Not applicable
- Monotherapy Versus Dual Therapy for Initial Treatment for HypertensionStatus unknownNCT00994617Phase 4
- Development of Cocktail for Measuring the Activity of Important Cytochrome P450 EnzymesTerminatedNCT00981929Not applicable
- Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I HypertensionCompletedNCT00971165Phase 3